Gerrit Dispersyn - Net Worth and Insider Trading

Gerrit Dispersyn Net Worth

The estimated net worth of Gerrit Dispersyn is at least $6,273 dollars as of 2024-05-22. Gerrit Dispersyn is the President & CEO of Phio Pharmaceuticals Corp and owns about 7,940 shares of Phio Pharmaceuticals Corp (PHIO) stock worth over $6,273. Details can be seen in Gerrit Dispersyn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gerrit Dispersyn has not made any transactions after 2021-08-16 and currently still holds the listed stock(s).

Transaction Summary of Gerrit Dispersyn

To

Gerrit Dispersyn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerrit Dispersyn owns 1 companies in total, including Phio Pharmaceuticals Corp (PHIO) .

Click here to see the complete history of Gerrit Dispersyn’s form 4 insider trades.

Insider Ownership Summary of Gerrit Dispersyn

Ticker Comapny Transaction Date Type of Owner
PHIO Phio Pharmaceuticals Corp 2021-08-16 Chief Development Officer

Gerrit Dispersyn Latest Holdings Summary

Gerrit Dispersyn currently owns a total of 1 stock. Gerrit Dispersyn owns 7,940 shares of Phio Pharmaceuticals Corp (PHIO) as of August 16, 2021, with a value of $6,273.

Latest Holdings of Gerrit Dispersyn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PHIO Phio Pharmaceuticals Corp 2021-08-16 7,940 0.79 6,273

Holding Weightings of Gerrit Dispersyn


Gerrit Dispersyn Form 4 Trading Tracker

According to the SEC Form 4 filings, Gerrit Dispersyn has made a total of 4 transactions in Phio Pharmaceuticals Corp (PHIO) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Phio Pharmaceuticals Corp is the acquisition of 500 shares on August 16, 2021, which cost Gerrit Dispersyn around $9,780.

Insider Trading History of Gerrit Dispersyn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gerrit Dispersyn Trading Performance

GuruFocus tracks the stock performance after each of Gerrit Dispersyn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerrit Dispersyn is -16.85%. GuruFocus also compares Gerrit Dispersyn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerrit Dispersyn within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gerrit Dispersyn's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gerrit Dispersyn

Average Return

Average return per transaction

Outperforming Transactions

0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.11
Relative Return to S&P 500(%) 5.77

Gerrit Dispersyn Ownership Network

Ownership Network List of Gerrit Dispersyn

No Data

Ownership Network Relation of Gerrit Dispersyn


Gerrit Dispersyn Owned Company Details

What does Phio Pharmaceuticals Corp do?

Who are the key executives at Phio Pharmaceuticals Corp?

Gerrit Dispersyn is the Chief Development Officer of Phio Pharmaceuticals Corp. Other key executives at Phio Pharmaceuticals Corp include Chief Development Officer John A Barrett , director & President and CEO Geert Cauwenbergh , and Chief Business Officer Alexey Eliseev .

Phio Pharmaceuticals Corp (PHIO) Insider Trades Summary

Over the past 18 months, Gerrit Dispersyn made no insider transaction in Phio Pharmaceuticals Corp (PHIO). Other recent insider transactions involving Phio Pharmaceuticals Corp (PHIO) include a net purchase of 13,215 shares made by Robert J Bitterman , and a net purchase of 9,000 shares made by Robert L Ferrara .

In summary, during the past 3 months, insiders sold 0 shares of Phio Pharmaceuticals Corp (PHIO) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Phio Pharmaceuticals Corp (PHIO) were sold and 7,810 shares were bought by its insiders, resulting in a net purchase of 7,810 shares.

Phio Pharmaceuticals Corp (PHIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Phio Pharmaceuticals Corp Insider Transactions

No Available Data

Gerrit Dispersyn Mailing Address

Above is the net worth, insider trading, and ownership report for Gerrit Dispersyn. You might contact Gerrit Dispersyn via mailing address: 257 Simarano Drive, Suite 101, Marlborough Ma 01752.

Discussions on Gerrit Dispersyn

No discussions yet.